African American Eye Disease Study
非洲裔美国人眼病研究
基本信息
- 批准号:9143126
- 负责人:
- 金额:$ 268.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAdultAfricanAfrican AmericanAgeAge related macular degenerationAgingAreaBaltimoreBehavioralBiologicalBiologyBlindnessBlood flowCaringChildhoodChinese AmericanClinicalClinical TrialsDataDevelopmentDiabetes MellitusDiabetic RetinopathyDiseaseEpidemiologic StudiesEthnic groupEvaluationExhibitsEyeEye diseasesGlaucomaGlycosylated hemoglobin AGoalsHabitsHappinessHealthHigh PrevalenceHispanicsHypertensionHypotensionIncidenceKnowledgeLatinoLens OpacitiesLos AngelesMarylandMeasuresMinorityNot Hispanic or LatinoObesityOpen-Angle GlaucomaParticipantPatternPersonsPhysiologic Intraocular PressurePopulationPrevalencePreventive measureProtocols documentationQuality of lifeRecommendationRecording of previous eventsReportingRetinalRiskRisk FactorsSmokingSurveysTestingUnited StatesUpdateVisual impairmentage relatedagedblood pressure reductionclinical practiceclinical riskcohortdesignexperiencefollow-upglycemic controlhealth related quality of lifehigh riskpopulation basedprogramsracial and ethnicscreeningskillstreatment program
项目摘要
DESCRIPTION (provided by applicant): African Americans (AAs) are one of the largest minority populations in the United States. In 2011, 43.2 million persons in the US (14.1%) were of African ancestry. AAs exhibit a different pattern of eye disease than other racial/ethnic groups
and are largely under-represented in studies of eye disease. Specifically, AAs are believed to have higher rates of visual impairment, blindness, open angle glaucoma (OAG), diabetic retinopathy (DR) but lower rates of age-related macular degeneration (AMD) than Non-Hispanic Whites (NHW) (1-5). However, most of the data that inform our estimates of the burden of eye disease in AAs are from two population based assessments initiated and conducted 20-28 years ago in Maryland (The Baltimore Eye Survey [1985-88] and The Salisbury Eye Evaluation Project [1993-95] (1, 6)). Since the completion of these two population-based studies, results of numerous clinical trials have reported the benefits of tighter glycemic control on the development of DR, and lower intraocular pressure on the development and progression of glaucoma. Findings from these two population based studies (showing the higher risk of vision loss, OAG and DR in AAs) have been incorporated into screening programs and clinical practice. Finally, with the aging of the U.S. population, the burden of age-related eye disease is likely to increase among AAs who are disproportionately impacted by obesity and diabetes. Given the implementation of numerous screening programs on AAs, the aging of the AA population, important changes in clinical practice, and the lack of recent population-based prevalence estimates, updated estimates of the burden of eye disease in AAs are needed. Characterization of the prevalence, the biological mechanisms (i.e., the risk relationships) of these diseases, and their impact on activities of daily life needs to be completed to allow for planning of preventive measures, and targeted screening and treatment programs. Further, it is crucial to determine the underlying reasons AAs may receive less follow-up eye care. Finally, while current data exists on the incidence of eye disease in NHW and Latinos, this study creates a cohort for obtaining the first incidence data on eye disease in AAs.
描述(由申请人提供):非洲裔美国人(AAS)是美国最大的少数民族之一。 2011年,美国有4320万人(14.1%)是非洲血统。 AA表现出与其他种族/种族不同的眼科疾病模式
并且在眼睛疾病研究中的代表性很大。具体而言,据信AA具有更高的视觉障碍,失明,开角青光眼(OAG),糖尿病性视网膜病(DR),但与非西班牙裔白人(NHW)相比,与年龄相关的黄斑变性(AMD)的速率更低(1-5)。然而,大多数依据AAS估计估计的数据的数据来自20 - 28年前在马里兰州开始并进行的两项基于人群的评估(巴尔的摩眼睛调查[1985-88]和索尔兹伯里眼睛评估项目[1993-95](1,6))。自从这两项基于人群的研究完成以来,众多临床试验的结果报道了严格控制对DR的发展的好处,以及较低的眼内压力对青光眼的发展和进展。这两项基于人群的研究的发现(显示较高的视力丧失风险,AAS中的OAG和DR)已纳入筛查计划和临床实践中。最后,随着美国人群的老龄化,与肥胖和糖尿病影响不成比例影响的AA相关眼科疾病的负担可能会增加。鉴于实施了有关AAS的众多筛查计划,AA人群的衰老,临床实践的重要变化以及最近基于人群的患病率估计值,需要更新AAS中眼病负担的估计。需要完成这些疾病的患病率,生物学机制(即风险关系)的表征,以及它们对日常生活活动的影响需要完成,以允许计划预防措施以及有针对性的筛查和治疗计划。此外,确定AAS可能会更少的后续眼保健的根本原因至关重要。最后,尽管目前存在有关NHW和Latinos眼病的发病率的数据,但该研究创造了一个同类,以获取AAS中有关眼病的首次发病率数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROHIT VARMA其他文献
ROHIT VARMA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROHIT VARMA', 18)}}的其他基金
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Environmental Moderation of Genetic Influences on Dementia Risk in Mexican Older Adults
环境调节基因对墨西哥老年人痴呆风险的影响
- 批准号:
10607226 - 财政年份:2023
- 资助金额:
$ 268.96万 - 项目类别:
Home-Based Self-Management of Chronic Pain in Adults with Sickle Cell Disease: Applying a Biopsychosocial and Technological Approach
镰状细胞病成人慢性疼痛的家庭自我管理:应用生物心理社会和技术方法
- 批准号:
10375569 - 财政年份:2021
- 资助金额:
$ 268.96万 - 项目类别:
Home-Based Self-Management of Chronic Pain in Adults with Sickle Cell Disease: Applying a Biopsychosocial and Technological Approach
镰状细胞病成人慢性疼痛的家庭自我管理:应用生物心理社会和技术方法
- 批准号:
10192113 - 财政年份:2021
- 资助金额:
$ 268.96万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10437374 - 财政年份:2021
- 资助金额:
$ 268.96万 - 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
- 批准号:
10654831 - 财政年份:2021
- 资助金额:
$ 268.96万 - 项目类别: